SCL
SCL
NYSE · Chemicals

Stepan Co

$66.49
+0.55 (+0.83%)
Financial Highlights (FY 2026)
Revenue
2.22B
Net Income
44.73M
Gross Margin
11.6%
Profit Margin
2.0%
Rev Growth
-5.6%
D/E Ratio
0.50
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 11.6% 11.6% 37.5% 37.5%
Operating Margin 3.4% 3.0% 18.6% 21.3%
Profit Margin 2.0% 1.9% 16.8% 17.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 2.22B 2.36B 534.44M 548.87M
Gross Profit 257.35M 272.64M 200.60M 206.02M
Operating Income 74.96M 71.47M 99.56M 116.77M
Net Income 44.73M 42.65M 89.73M 98.08M
Gross Margin 11.6% 11.6% 37.5% 37.5%
Operating Margin 3.4% 3.0% 18.6% 21.3%
Profit Margin 2.0% 1.9% 16.8% 17.9%
Rev Growth -5.6% -5.6% +12.4% -5.1%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 258.37M 258.37M 432.31M 552.46M
Total Equity 512.84M 512.84M 709.72M 796.21M
D/E Ratio 0.50 0.50 0.61 0.69
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA 195.13M 196.39M 145.33M 140.69M
Free Cash Flow — — 107.46M 73.33M